3D-image-guided HDR-brachytherapy versus 2D HDR - brachytherapy after external beam radiotherapy for early T-stage nasopharyngeal carcinoma.
3D-image-guided HDR-brachytherapy versus 2D HDR - brachytherapy after external beam radiotherapy for early T-stage nasopharyngeal carcinoma.
复制标题
早期 T 期鼻咽癌外照射放疗后 3D 图像引导 HDR 近距离放射治疗与 2D HDR 近距离放射治疗的比较
DOI:
10.1186/1471-2407-14-894
复制
发表时间:
2014-11-29
期刊:
影响因子:
3.8
通讯作者:
Wen B
中科院分区:
文献类型:
--
作者:
Ren Y;Zhao Q;Liu H;Huang Y;Wang Z;Cao X;Teh BS;Wen B
Background:Two-dimensional high-dose-rate brachytherapy (2D-HDR-BT) is an effective method of dose escalation for local tumor control in early T-stage nasopharyngeal carcinoma (NPC). Treatment outcomes for 3D-image-guided high-dose-rate brachytherapy (3D-image-guided-HDR-BT) after external beam radiotherapy (ERT) have not been examined in early T-stage NPC patients. The current study was designed to evaluate whether addition of 3D-HDR-BT to ERT showed further improvement in treatment outcomes in patients with early T-stage NPC when compared to 2D-HDR-BT after ERT.Methods:The current study retrospectively analyzed and compared treatment outcomes for patients with nonmetastatic stage T1-2b NPC treated with 2D-HDR-BT (n =101) or 3D-HDR-BT (n =118) after ERT. Patients in both groups were treated with ERT at a mean dose of 60 Gy and a brachytherapy dose of 12Gy (8 ~ 20Gy), 2.5 ~ 5Gy per fraction under local anesthesia.Results:Compared to patients treated with 2D-HDR-BT after ERT, patients treated with 3D-HDR-BT after ERT showed improvement in five-year actuarial local control survival rates (p = 0.024), local/regional relapse-free survival rates (p = 0.038), and disease-free survival rates (p = 0.021). Multivariate analysis showed that NPC patients treated with 3D-HDR-BT had improved local control survival (p = 0.042). The incidence rates of acute or chronic complications were similar between two groups.Conclusions:The current study showed that 3D-image-guided HDR-BT after ERT was an effective treatment modality for patients with stage T1-2 NPC with acceptable complications. The improvement in local tumor control and disease free survival is likely due to improved conformal dose distributions.
登录
查看更多内容
影响因子:
1.9
作者:
Levendag, Peter C.;Keskin-Cambay, Fatma;Teguh, David N.
通讯作者:
Teguh, David N.
影响因子:
1.2
作者:
Osewski, Wojciech;Dolla, Lukasz;Slosarek, Krzysztof
通讯作者:
Slosarek, Krzysztof
DOI:
10.1016/s0360-3016(99)00326-0
发表时间:
2000-01-15
影响因子:
7
作者:
Teo, PML;Leung, SF;Zee, B
通讯作者:
Zee, B
影响因子:
51.1
作者:
Chen, Lei;Hu, Chao-Su;Ma, Jun
通讯作者:
Ma, Jun
影响因子:
8.8
作者:
Peto R;Pike MC;Armitage P;Breslow NE;Cox DR;Howard SV;Mantel N;McPherson K;Peto J;Smith PG
通讯作者:
Smith PG